Senior Vice President, Chief Medical Officer · ENANTA PHARMACEUTICALS INC (ENTA)

Nathalie Adda

A named executive officer of ENANTA PHARMACEUTICALS in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,813,418

Salary $451,550Stock awards $187,821

FY2019: $1,494,622

3rd of 5 named executive officers at Enanta Pharmaceuticals by FY2020 total.

5 named officers on file for ENANTA PHARMACEUTICALS, FY2020

Nathalie Adda’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 9 equity grants, each cited to its filing
  • ENTA’s disclosed peer group of 21 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ENANTA PHARMACEUTICALS’s whole pay program stands against its peers

  • ENANTA PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ENTA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed January 21, 2021 (DEF 14A).

Free

Get Nathalie Adda’s full pay file as a PDF — free

More than this page: up to 10 years of Nathalie’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Nathalie Adda compensation by year

ENANTA PHARMACEUTICALS Summary Compensation Table · all 5 fiscal years held
In US dollars, as ENANTA PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$383,438$400,313$421,425$421,425$451,550
Bonus$52,500$0$0$0$0
Stock awards$162,081$574,369$275,275$275,275$187,821
Option awards$317,482$599,585$630,855$630,855$981,504
Non-equity incentive$65,625$159,521$167,670$148,216$173,372
Pension and deferred compensation$0$0$0$0$0
All other$15,857$18,551$18,851$18,851$19,171
Total$996,983$1,752,339$1,514,076$1,494,622$1,813,418

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ENANTA PHARMACEUTICALS INC DEF 14A filed January 21, 2021, accession 0001564590-21-001788, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ENANTA PHARMACEUTICALS INC filed document, accession 0001564590-21-001788. Every figure is read from that document and cited to the page and table it appears in. Filed January 21, 2021.

$997K
$1.8M
$1.5M
$1.5M
$1.8M
FY16
FY17
FY18
FY19
FY20
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU5,250$240,345—
PSU4,100$187,698—
PSU2,200$100,716—
PSU2,200$100,716—
Option7,344—$48.52
Option2,188—$30.00
Option11,250—$81.20
Option24,375—$63.35

Per the Outstanding Equity Awards at Fiscal Year-End table in ENANTA PHARMACEUTICALS INC's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

ENANTA PHARMACEUTICALS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Jay LulyPresident and Chief Executive Officer$5,197,837
Yat OrSenior Vice President, Research & Development and Chief Scientific Officer$1,844,801
Nathalie Adda · this pageSenior Vice President, Chief Medical Officer$1,813,418
Nathaniel GardinerSenior Vice President and General Counsel$1,788,991
Paul MellettSenior Vice President, Finance & Administration and Chief Financial Officer$1,781,843

The full ENANTA PHARMACEUTICALS compensation record

free company brief

This page is one person within ENANTA PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ENANTA PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ENANTA PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Nathalie Adda's compensation dossier · One-time report. No refunds.